1H-[1,2,4]Triazolo[3,4-b]purine-1-ethanamine, 4-[(2S,5R)-4-[bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-N,N-dimethyl-

1H-[1,2,4]Triazolo[3,4-b]purine-1-ethanamine, 4-[(2S,5R)-4-[bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-N,N-dimethyl- structure

CAS No.: 3023735-35-2

Chemical Name:: 1H-[1,2,4]Triazolo[3,4-b]purine-1-ethanamine, 4-[(2S,5R)-4-[bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-N,N-dimethyl-

Synonyms: DGK-IN-12;1H-[1,2,4]Triazolo[3,4-b]purine-1-ethanamine, 4-[(2S,5R)-4-[bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-N,N-dimethyl-

CBNumber:: CB221543049

Molecular Formula:: C29H33F2N9

Molecular Weight:: 545.63

MDL Number:

MOL File:: 3023735-35-2.mol

Last updated:2025-10-31 08:01:17

Request For Quotation

1H-[1,2,4]Triazolo[3,4-b]purine-1-ethanamine, 4-[(2S,5R)-4-[bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-N,N-dimethyl- Properties

Density	1.355±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka	8.857±0.28(predicted)

1H-[1,2,4]Triazolo[3,4-b]purine-1-ethanamine, 4-[(2S,5R)-4-[bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-N,N-dimethyl- Preparation Products And Raw materials

Raw materials

Preparation Products

1H-[1,2,4]Triazolo[3,4-b]purine-1-ethanamine, 4-[(2S,5R)-4-[bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-N,N-dimethyl- Suppliers

Global Suppliers ( 1)

Supplier	Tel	Email	Country	ProdList	Advantage
Shanghai Beckham Medical Technology Co., Ltd	13816613772	huahero21@sina.com	China	2994	55

Supplier	Advantage
Shanghai Beckham Medical Technology Co., Ltd	55

3023735-35-2 (1H-[1,2,4]Triazolo[3,4-b]purine-1-ethanamine, 4-[(2S,5R)-4-[bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-N,N-dimethyl-) Related Search:

COCHLIOQUINONE A 1,5-Naphthyridine-2-carbonitrile, 5,6-dihydro-3-(2-hydroxyethoxy)-5-methyl-8-[4-(5-methyl-2-benzoxazolyl)-1-piperidinyl]-6-oxo- 8-[(2S,5R)-4-[Bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-5-methyl-6-oxo-5,6-dihydro-1,5-naphthyridine-2-carbonitrile 1,5-Naphthyridine-2-carbonitrile, 8-[(2S,5R)-4-[bis(4-chlorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-5,6-dihydro-5-methyl-6-oxo- 6-Fluoro-1-methyl-4-[4-(5-methyl-2-benzoxazolyl)-1-piperidyl]-2-oxo-1,2-dihydroquinoline-3-carboxamide

1H-[1,2,4]Triazolo[3,4-b]purine, 4-[(2S,5R)-4-[(3,3-difluorocyclobutyl)[4-(trifluoromethyl)phenyl]methyl]-2,5-dimethyl-1-piperazinyl]-2-methyl-1-[[(2S)-tetrahydro-2-furanyl]methyl]-

1of2

1H-[1,2,4]Triazolo[3,4-b]purine-1-ethanamine, 4-[(2S,5R)-4-[bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-N,N-dimethyl- DGK-IN-12 3023735-35-2